According to Emergen Research, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market size was USD 3,226.04 million in 2020 and is expected to reach USD 4,821.04 million in 2028 and register a revenue CAGR of 5.1% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Antimicrobial Susceptibility Testing/Antibiotic Sensitivity Testing Market, By Component (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Culture & Growth Media, Consumables), By Type (Antibacterial Susceptibility/Sensitivity Testing, Antiparasitic Susceptibility/Sensitivity Testing, Antifungal Susceptibility/Sensitivity Testing, Others), By Method (Disk Diffusion, E-test Method, Automated Susceptibility Testing Instruments, Genotyping Method, Agar Dilution, Others), By Application (Drug Discovery & Development, Clinical Diagnostics, Epidemiology, Others), By End-use (Hospitals & Clinics, Pharmaceutical Companies, Diagnostic Centers, Research Institutes, Clinical Research Organizations), and By Region, Forecast to 2028”
According to Emergen Research, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market size was USD 3,226.04 million in 2020 and is expected to reach USD 4,821.04 million in 2028 and register a revenue CAGR of 5.1% during the forecast period, 2021-2028.
Market Dynamics:
The global antimicrobial susceptibility testing/antibiotic sensitivity testing market revenue growth is primarily attributed to factors such as rising cases of infectious diseases including the SARS-CoV-2, increasing awareness of infectious diseases among the public, rising volumes of antimicrobial susceptibility testing/antibiotic sensitivity testing procedures, and recent advances in COVID-19 disease diagnostics. Antimicrobial susceptibility testing/antibiotic sensitivity tests detect the level of microbial or bacterial resistance to antibiotics in an individual. Increasing commercial applications of antimicrobial susceptibility testing (AST) systems, rising focus of regulatory bodies including the WHO, EU, and Global Sepsis Alliance (GSA) on improving the safety and efficacy AST methods, rise in research activities for development of more advanced antimicrobial susceptibility/antibiotic sensitivity testing solutions, and increasing government investments in the healthcare industry are among the other key contributors to market revenue growth. However, some of the key restraints to the global market revenue growth are rising costs of automated antimicrobial susceptibility/antibiotic sensitivity testing equipment and lack of operational skills among laboratory personnel.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/381
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Manual Antimicrobial Susceptibility Testing Products Segment to Account for Fastest Revenue CAGR:
Based on component, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market is segmented into manual antimicrobial susceptibility testing products, automated laboratory instruments, culture & growth media, and consumables. The manual antimicrobial susceptibility testing products segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Increasing cases of COVID-19 globally, growing number of antimicrobial susceptibility testing procedures, increasing susceptibility of people (especially the younger and geriatric groups) to the novel coronavirus disease, and rising demand for manual antimicrobial susceptibility testing products such as MIC strips and susceptibility testing disks are key factors driving revenue growth of this segment.
Clinical Diagnostics Segment Accounted for Largest Revenue Share in 2020:
Based on application, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market is segmented into drug discovery & development, clinical diagnostics, epidemiology, and others. The clinical diagnostics segment held the largest revenue share in the global market in 2020 due to many favorable factors. Major factors boosting the revenue growth of this segment are rising cases of infectious diseases including the novel coronavirus disease and hospital-acquired diseases (HAIs), increasing volumes of clinical diagnostic tests, rising awareness of early disease diagnosis, and emergence of advanced AST equipment and solutions.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America antimicrobial susceptibility testing/antibiotic sensitivity testing market dominated other regions in terms of revenue share in the global market in 2020. Key factors contributing to the regional market revenue growth are increasing COVID-19 cases in the region, technological advancements in antimicrobial susceptibility testing solutions, increasing focus on development of automated AST systems, and presence of leading market players in North America, including Becton, Dickinson and Company, Thermo Fisher Scientific, and Bruker Corporation.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/381
Major Companies in the Global Market Include:
- Danaher Corporation
- Merck KGaA
- HiMedia Laboratories
- Bruker Corporation
- BioMerieux SA
- Bio-Rad Laboratories
- Precise Automation
- Roche Diagnostics
- Accelerate Diagnostics Inc.
- Becton, Dickinson, and Company
- Liofilchem S.r.l.
- Alifax S.r.l.
- Creative Diagnostics
- Synbiosis
- Bioanalyse
- ELITechGroup
- Mast Group Ltd.
- CONDALAB
- Genefluidics, Inc.
- InvivoGen
- ZHUHAI DL BIOTECH Co., Ltd.
- QuantaMatrix Inc.
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/antimicrobial-susceptibility-testing-market
For the purpose of this report, Emergen Research has segmented the global antimicrobial susceptibility testing/antibiotic sensitivity testing market based on component, type, method, application, end-use, and region:
Component Outlook (Revenue, USD Million; 2018-2028)
- Manual Antimicrobial Susceptibility Testing Products
- Automated Laboratory Instruments
- Culture & Growth Media
- Consumables
Type Outlook (Revenue, USD Million; 2018-2028)
- Antibacterial Susceptibility/Sensitivity Testing
- Antiparasitic Susceptibility/Sensitivity Testing
- Antifungal Susceptibility/Sensitivity Testing
- Others
Method Outlook (Revenue, USD Million; 2018-2028)
- Disk Diffusion
- E-test Method
- Automated Susceptibility Testing Instruments
- Genotyping Method
- Agar Dilution
- Others
Application Outlook (Revenue, USD Million; 2018-2028)
- Drug Discovery & Development
- Clinical Diagnostics
- Epidemiology
- Others
End-use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals & Clinics
- Pharmaceutical Companies
- Diagnostic Centers
- Research Institutes
- Clinical Research Organizations
By Region (Revenue, USD Million; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore our reports from Healthcare Catogory:
Increasing advancements in sequencing techniques, benefits of Sanger’s sequencing, and rising investments to accelerate R&D activities in genomics research are key factors expected to drive sanger sequencing services market revenue growth over the forecast period.
Advancements in genomic research, rapid adoption of cutting-edge technologies, and increasing awareness about whole exome sequencing technology are key factors expected to drive whole exome sequencing (WES) market revenue growth over the forecast period.
The global health data archiving market size was USD 3.21 Billion in 2020 and is expected to reach USD 9.28 Billion in 2028 and register a CAGR of 14.1%. Healthcare data archiving industry report classifies global market by share, trend, growth and on the basis of type, storage system, deployment, architecture, end-use, and region.
The global naval Intelligence, Surveillance, Reconnaissance market size was USD 13.17 Billion in 2020 and is expected to reach USD 16.24 Billion in 2028 registering a CAGR of 2.6%. Naval ISR industry report classifies global market by share, trend, growth and on the basis of vessel type, application, and region.
The global emerging memory technologies market size reached USD 4.17 Billion in 2020 and is expected to reach USD 34.66 Billion in 2028 registering a CAGR of 30.7%. Emerging memory technologies industry report classifies global market by share, trend, growth and on the basis of technology, application, and region.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-antimicrobial-susceptibility-testing-market